Based on tumour cellularity, Ki‐67 positivity and proliferating cell nuclear antigen (PCNA), together with clinical stage and histological differentiation, provided additional useful information for predicting lung cancer evolution and prognosis. The gene discussed is PCNA; the disease is lung cancer.